Nadav Friedmann - 31 Dec 2022 Form 5 Insider Report for CASSAVA SCIENCES INC (SAVA)

Reporting relationship
Chief Medical Officer, Director
Issuer ticker
SAVA
Reported as of
31 Dec 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
5
Accepted by SEC
03 Jan 2023, 15:16:47 UTC
Prior SEC filing
03 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric J. Schoen - Chief Financial Officer

Key filing fact

Nadav Friedmann filed Form 5 for CASSAVA SCIENCES INC (SAVA) on 03 Jan 2023.

Key facts

  • This page summarizes Nadav Friedmann's Form 5 filing for CASSAVA SCIENCES INC (SAVA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Jan 2023, 15:16.

Change

  • Previous filing in this sequence was filed on 03 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SAVA transaction

Common Stock

Gift

Transaction value
$0
Shares
-10
Change %
-0.01%
Price
$0.000000
Shares after
79,900
Date
31 Jan 2022
Ownership
Direct
Footnotes
F1
SAVA transaction

Common Stock

Gift

Transaction value
$0
Shares
-990
Change %
-1.2%
Price
$0.000000
Shares after
78,910
Date
15 Mar 2022
Ownership
Direct
Footnotes
F1
SAVA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
143
Date
31 Dec 2022
Ownership
By Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Bona Fide Gift

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .